We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

189 hedge funds and large institutions have $1.91B invested in Heron Therapeutics in 2020 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 52 increasing their positions, 64 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

145% more call options, than puts

Call options by funds: $2.94M | Put options by funds: $1.2M

42% more capital invested

Capital invested by funds: $1.34B → $1.91B (+$567M)

37% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 19

4% more funds holding

Funds holding: 182 → 189 (+7)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

0.63% less ownership

Funds ownership: 99.99% → 99.36% (-0.63%)

19% less repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 64

Holders
189
Holders Change
+7
Holders Change %
+3.85%
% of All Funds
3.34%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
26
Increased
52
Reduced
64
Closed
19
Calls
$2.94M
Puts
$1.2M
Net Calls
+$1.74M
Net Calls Change
+$1.8M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$57.7M
2
BlackRock
BlackRock
New York
+$18.4M
3
ITP
Iron Triangle Partners
Connecticut
+$15M
4
Citadel Advisors
Citadel Advisors
Florida
+$9.38M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$5.4M

Top Sellers

1
TCM
Tang Capital Management
California
-$42.9M
2
CCM
Consonance Capital Management
New York
-$29.7M
3
KCM
Kensico Capital Management
Connecticut
-$8.03M
4
State Street
State Street
Massachusetts
-$7.45M
5
Fidelity International
Fidelity International
Bermuda
-$7.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
Franklin Resources
1
Franklin Resources
California
$269M -$3.4M -195,662 -2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$176M +$5.4M +310,669 +4%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$147M +$57.7M +3,322,618 +92%
BlackRock
4
BlackRock
New York
$146M +$18.4M +1,060,614 +18%
BBA
5
Baker Bros. Advisors
New York
$127M – – –
ACH
6
ArrowMark Colorado Holdings
Colorado
$113M +$5.25M +302,085 +6%
State Street
7
State Street
Massachusetts
$84.3M -$7.45M -428,430 -10%
ClearBridge Investments
8
ClearBridge Investments
New York
$73.1M +$316K +18,181 +0.5%
JP Morgan Chase
9
JP Morgan Chase
New York
$65.6M +$2.12M +122,187 +4%
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$47.9M +$2.93M +168,612 +8%
PHS
11
PFM Health Sciences
California
$42.6M +$2.42M +139,465 +7%
Invesco
12
Invesco
Georgia
$36.5M -$243K -13,997 -0.8%
RCAMU
13
Rothschild & Co Asset Management US
Connecticut
$28.6M -$4.48M -257,845 -16%
Artisan Partners
14
Artisan Partners
Wisconsin
$28.4M +$4.15M +238,842 +22%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$27.6M +$824K +47,381 +4%
CS
16
Candriam SCA
Luxembourg
$27.3M -$507K -29,199 -2%
CWG
17
C WorldWide Group
Denmark
$25.4M +$5.21M +300,000 +33%
O
18
OrbiMed
New York
$25.2M – – –
Norges Bank
19
Norges Bank
Norway
$24.7M -$3.71M -213,666 -15%
Goldman Sachs
20
Goldman Sachs
New York
$24.3M +$2M +114,958 +11%
Fidelity Investments
21
Fidelity Investments
Massachusetts
$23.1M -$610K -35,072 -3%
Northern Trust
22
Northern Trust
Illinois
$21.2M -$398K -22,915 -2%
PCM
23
Palisade Capital Management
New Jersey
$18.9M +$1.22M +70,079 +9%
ITP
24
Iron Triangle Partners
Connecticut
$18.3M +$15M +865,072 New
NAM
25
Nexpoint Asset Management
Texas
$15.3M – – –
1
2 3 4 5

HRTX Hedge Fund Activity: Q4 2020 in Review

189 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q4 2020, worth a combined $1.91B — up 42% from $1.34B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new HRTX positions and 19 closed out — a net gain of 7 holders — while 52 added to existing stakes and 64 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $57.7M. The largest seller was Tang Capital Management, exiting entirely with an estimated $42.9M sold.

  • 189 institutional investors held Heron Therapeutics (HRTX) as of Q4 2020, up from 182 in Q3 2020.
  • Funds reported $1.91B of Heron Therapeutics stock for Q4 2020, up 42% quarter-over-quarter.
  • 26 funds opened new Heron Therapeutics positions in Q4 2020 and 19 closed out, a net change of +7 holders.
  • The largest Heron Therapeutics buyer in Q4 2020 was Wellington Management Group, an estimated $57.7M added.
  • The largest Heron Therapeutics seller in Q4 2020 was Tang Capital Management, an estimated $42.9M sold.

Based on aggregated 13F filings for Q4 2020.